Worldwide incidence of ESRD figure 12.1, per million population

Slides:



Advertisements
Similar presentations
UK Renal Registry 15th Annual Report Figure One year death rate per 1,000 patient years by UK country and age group for prevalent dialysis.
Advertisements

Chapter 4: Hospitalization 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Vol 2, ESRD, Ch ANNUAL DATA REPORT VOLUME 2: END-STAGE RENAL DISEASE Chapter 9: Costs of ESRD.
Treated ESRD Incidence Rates for Selected Countries, New ESRD Patients/Million Pop. Year of ESRD Incidence USA (All) JPN* USA (White) CAN FRA NL.
Chapter 2: Healthy People A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
DEVELOPMENT OF STRATEGIES FOR PREVENTION OF CHRONIC KIDNEY DISEASE RELEVENT TO DIFFERENT REGIONS AND COUNTRIES ROBERT C ATKINS BELLAGIO, MARCH 2004.
Vol 2 Figure 1.1 Trends in the number of incident cases of ESRD, in thousands, by modality, in the U.S. population, Data Source: Reference.
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
Chapter 5: Mortality 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
© ANZDATA Registry Method and Location of Dialysis 1453 (30%) 632 (13%) 1317 (27%) 1335 (27%) Number of Patients Australia 31-Dec-96.
UK Renal Registry 14th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2010.
UK Renal Registry 17th Annual Report Figure 2.1. Prevalence rates per million population by age group and UK country on 31/12/2013.
Healthy People 2010 Focus Area 4
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 8: Pediatric ESRD.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 6: Mortality.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 7: Transplantation.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 11: Costs of ESRD.
UK Renal Registry 15th Annual Report Figure D.1. 95% confidence limits for incidence of 108 pmp for population size 80,000–800,000.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 10: Dialysis Providers.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 13: International Comparisons.
USRDS 1999 Point Prevalence Counts by Modality, Data Source, and Year, Count (1000s) Year Center Hemo Functioning Transplant PD Home Hemo Facility.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 5: Hospitalization.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 2: Healthy People 2020.
ESRD Prognoses James Heaf. This Power Point presentation belongs to the Danish Renal Registry, which owns the copyright. It can be freely used.
CHAPTER 2 DIALYSIS IN MALAYSIA Goh Bak Leong Lim Yam Ngo Ong Loke Meng Ghazali Ahmad Lee Day Guat Source: 20 th MDTR Report 2012, NRR.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Similar Outcomes With Hemodialysis and Peritoneal.
USRDS USRDS 2002 adr Period prevalent ESRD patient, deaths, & ESRD expenditures figure 12.1.
USRDS 2000 ADR USRDS Hepatitis B vaccine & antibody among patients & unit staff figure 9.1, dialysis patients, 1997, by network.
USRDS USRDS 2002 adr Incident counts by initial modality figure 7.1 patients age 19 years & younger.
USRDS 2000 ADR USRDS Cadaveric donations by gender & race figure 7.1, patients aged
2016 Annual Data Report, Vol 2, ESRD, Ch 13
2016 Annual Data Report, Vol 2, ESRD, Ch 5
Section 1: CKD Epidemiology
Figure 11.1 Trends in ESRD expenditures,
2016 Annual Data Report, Vol 2, ESRD, Ch 6
Healthy People 2010 targets & levels achieved in 2000 figure hp.1
Figure 10.1 Dialysis unit counts, by unit affiliation, 2011–2014
Odd ratio of developing kidney failure figure 1
Volume 2: End-Stage Renal Disease International Comparisons
2017 Annual Data Report Healthy People 2020.
Volume 2: End-Stage Renal Disease Chapter 4: Hospitalization
Volume 2: End-Stage Renal Disease
December 31st point prevalent counts by modality figure 3.1
Hospital admissions per patient, by modality figure 5
UK Renal Registry 9th Annual Report 2006
Chapter 9: Healthcare Expenditures for Persons with ESRD
UK Renal Registry 10th Annual Report 2007
Volume 2: End-Stage Renal Disease
CHAPTER 5 Paediatric Renal Replacement Therapy
Figure 1.17 of the 2016 US Renal Data System Annual Data Report, Volume 2, chapter 1 showing the trends in the number of patients with incident ESRD (in.
2018 Annual Data Report Volume 3: Healthy People 2020
Volume 2: End-Stage Renal Disease Chapter 6: Transplantation
Number of dialysis & transplant units figure 10.1
Volume 64, Pages S3-S12 (December 2003)
Chapter 9: Healthcare Expenditures for Persons with ESRD
CHAPTER 1 All Renal Replacement Therapy In Malaysia
UK Renal Registry 15th Annual Report
Francesco Paolo Schena  Kidney International 
UK Renal Registry 16th Annual Report
New ESRD Patients and Main Sources
Reported ESRD Period and Point Prevalence,
Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study  Eric D.
American Journal of Kidney Diseases
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
E.A. Friedman, A.L. Friedman, P. Eggers  Kidney International 
Current status of maintenance hemodialysis in Beijing, China
UK Renal Registry 10th Annual Report 2007
Renal replacement therapy in Latin America
Douglas E. Schaubel, Howard I. Morrison, Stanley S.A. Fenton 
Maristela Böhlke, PhD  American Journal of Kidney Diseases 
Presentation transcript:

Worldwide incidence of ESRD figure 12.1, per million population USRDS

Worldwide prevalence of ESRD figure 12.2, per million population USRDS

Percent of patients worldwide on CAPD figure 12.3 USRDS

Percent of patients worldwide on home hemodialysis figure 12.4 USRDS

First transplant rates worldwide figure 12.5, per million population USRDS

Rates of functioning renal transplants worldwide figure 12 Rates of functioning renal transplants worldwide figure 12.6, per million population USRDS

Percent of patients worldwide with a functioning graft figure 12 Percent of patients worldwide with a functioning graft figure 12.7, prevalent ESRD patients USRDS

Percent of patients worldwide with diabetic nephropathy figure 12.8 USRDS